Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is characterized by glycemia and insulin disorders. Bile acids (BAs) have emerged as vital signaling molecules in glucose metabolic regulation. BA change in GDM is still unclear, which exerts great significance to illustrate the change of BAs in GDM. GDM patients and normal pregnant women were enrolled during the oral glucose tolerance test (OGTT) screening period. Fasting serums were sampled for the measurement of BAs. BA metabolism profiles were analyzed in both pregnant women with GDM and those with normal glucose tolerance (NGT). Delivery characteristics, delivery gestational age, and infant birthweight were extracted from medical records. GDM patients presented distinctive features compared with NGT patients, including higher body mass index (BMI), elevated serum glucose concentration, raised insulin (both fasting and OGTT), and increased hemoglobin A1c (HbA1c) levels. Higher homeostasis model assessment of insulin resistance (HOMA-IR) and decreased β-cell compensation (i.e., oral disposition index (DIo)) were also prevalent in this group. Total BAs (TBAs) remained stable, but glycodeoxycholic acid (GDCA) and taurodeoxycholic acid (TDCA) levels declined significantly in GDM. GDCA was inversely correlated with HOMA-IR and positively correlated with DIo. No obvious differences in clinical outcome between the GDM and NGT groups were observed. However, GDM patients with high HOMA-IR and low DIo tended to have a higher cesarean delivery rate and younger delivery gestational age. In conclusion, GDCA provides a valuable biomarker to evaluate HOMA-IR and DIo, and decreased GDCA levels predict poorer clinical outcomes for GDM.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Journal of Zhejiang University. Science. B - 22(2021), 3 vom: 15. März, Seite 223-232 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhu, Bo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
β-Cell compensation |
|---|
| Anmerkungen: |
Date Completed 05.11.2021 Date Revised 31.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1631/jzus.B2000483 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM322759811 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM322759811 | ||
| 003 | DE-627 | ||
| 005 | 20240331232907.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1631/jzus.B2000483 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1358.xml |
| 035 | |a (DE-627)NLM322759811 | ||
| 035 | |a (NLM)33719227 | ||
| 035 | |a (PII)1673-1581(2021)03-0223-10 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhu, Bo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reduced glycodeoxycholic acid levels are associated with negative clinical outcomes of gestational diabetes mellitus |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.11.2021 | ||
| 500 | |a Date Revised 31.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Gestational diabetes mellitus (GDM) is characterized by glycemia and insulin disorders. Bile acids (BAs) have emerged as vital signaling molecules in glucose metabolic regulation. BA change in GDM is still unclear, which exerts great significance to illustrate the change of BAs in GDM. GDM patients and normal pregnant women were enrolled during the oral glucose tolerance test (OGTT) screening period. Fasting serums were sampled for the measurement of BAs. BA metabolism profiles were analyzed in both pregnant women with GDM and those with normal glucose tolerance (NGT). Delivery characteristics, delivery gestational age, and infant birthweight were extracted from medical records. GDM patients presented distinctive features compared with NGT patients, including higher body mass index (BMI), elevated serum glucose concentration, raised insulin (both fasting and OGTT), and increased hemoglobin A1c (HbA1c) levels. Higher homeostasis model assessment of insulin resistance (HOMA-IR) and decreased β-cell compensation (i.e., oral disposition index (DIo)) were also prevalent in this group. Total BAs (TBAs) remained stable, but glycodeoxycholic acid (GDCA) and taurodeoxycholic acid (TDCA) levels declined significantly in GDM. GDCA was inversely correlated with HOMA-IR and positively correlated with DIo. No obvious differences in clinical outcome between the GDM and NGT groups were observed. However, GDM patients with high HOMA-IR and low DIo tended to have a higher cesarean delivery rate and younger delivery gestational age. In conclusion, GDCA provides a valuable biomarker to evaluate HOMA-IR and DIo, and decreased GDCA levels predict poorer clinical outcomes for GDM | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bile acid | |
| 650 | 4 | |a Gestational diabetes mellitus (GDM) | |
| 650 | 4 | |a Insulin resistance | |
| 650 | 4 | |a β-Cell compensation | |
| 650 | 7 | |a Insulin |2 NLM | |
| 650 | 7 | |a Glycodeoxycholic Acid |2 NLM | |
| 650 | 7 | |a 360-65-6 |2 NLM | |
| 700 | 1 | |a Ma, Zhixin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Yuning |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Lei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Kong, Hongwei |e verfasserin |4 aut | |
| 700 | 1 | |a Xia, Dajing |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Zhejiang University. Science. B |d 2005 |g 22(2021), 3 vom: 15. März, Seite 223-232 |w (DE-627)NLM152588027 |x 1862-1783 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:3 |g day:15 |g month:03 |g pages:223-232 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1631/jzus.B2000483 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 3 |b 15 |c 03 |h 223-232 | ||